PCSA icon

Processa Pharmaceuticals
PCSA

10 hedge funds and large institutions have $331K invested in Processa Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 6 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$211K
2
+$138K
3
+$88.3K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$84.2K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$22.3K

Top Sellers

1
-$202K
2
-$8K
3
-$6.96K
4
Citigroup
Citigroup
New York
-$6.53K
5
SG
StoneX Group
New York
-$3.64K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
1
Jane Street
New York
$86.9K
Vanguard Group
2
Vanguard Group
Pennsylvania
$67.9K
HF
3
HRT Financial
New York
$56K
Geode Capital Management
4
Geode Capital Management
Massachusetts
$44.1K
UBS Group
5
UBS Group
Switzerland
$36.4K
SCM
6
Stonepine Capital Management
Oregon
$35.5K
TRCT
7
Tower Research Capital (TRC)
New York
$4K
Bank of America
8
Bank of America
North Carolina
$52
Jones Financial Companies
9
Jones Financial Companies
Missouri
$20
Wells Fargo
10
Wells Fargo
California
$17
VF
11
Virtu Financial
New York
–
TSS
12
Two Sigma Securities
New York
–
Citigroup
13
Citigroup
New York
–
SG
14
StoneX Group
New York
–
SCA
15
Sassicaia Capital Advisers
New York
–
MMA
16
Miracle Mile Advisors
California
–